Palonosetron as an anti-emetic and anti-nausea agent in oncology

Autor Aapro, Matti S
Vydáno 2007

Mammography Screening and Treatment of Breast Cancer in the Elderly

Autor Aapro, Matti
Vydáno 2008

SIOG (International Society of Geriatric Oncology) recommendations for anthracycline use in the elderly

Autor Aapro, Matti
Vydáno 2011

Management of Advanced Prostate Cancer in Senior Adults: The New Landscape

Autor Aapro, Matti S.
Vydáno 2012

Age Does not Matter, Biology of Both Cancer and Patient Does

Autor Aapro, Matti S.
Vydáno 2012

Management of Advanced Prostate Cancer in Senior Adults: The New Landscape

Autor Aapro, Matti S.
Vydáno v Oncologist (2015)

Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting—concluding thoughts

Autor Aapro, Matti
Vydáno v Support Care Cancer (2018)

Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting—introduction

Autor Aapro, Matti
Vydáno v Support Care Cancer (2018)

CINV: still troubling patients after all these years

Autor Aapro, Matti
Vydáno v Support Care Cancer (2018)

The Role of Multigene Assays in Addressing Treatment Heterogeneity for Breast Cancer

Autor Aapro, Matti
Vydáno v Biomed Hub (2017)

Bone-modifying agents in the treatment of bone metastases in patients with advanced genitourinary malignancies: a focus on zoledronic acid

Autor Aapro, Matti, Saad, Fred
Vydáno 2012

Prevention of nausea and vomiting in cancer patients

Autor Aapro, Matti., Jordan, Karin., Feyer, Petra.
Vydáno 2013

Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?

Autor Aapro, Matti, Crawford, Jeffrey, Kamioner, Didier
Vydáno 2010

Optimizing Clinical Benefits of Bisphosphonates in Cancer Patients with Bone Metastases

Autor Aapro, Matti, Saad, Fred, Costa, Luis
Vydáno 2010

From guidelines to clinical practice: a roadmap for oncologists for nutrition therapy for cancer patients

Autor Muscaritoli, Maurizio, Arends, Jann, Aapro, Matti
Vydáno v Ther Adv Med Oncol (2019)

Comparative cost efficiency across the European G5 countries of originators and a biosimilar erythropoiesis-stimulating agent to manage chemotherapy-induced anemia in patients with...

Autor Aapro, Matti, Cornes, Paul, Sun, Diana, Abraham, Ivo
Vydáno 2012

Epoetin Biosimilars in the Treatment of Chemotherapy-Induced Anemia: 10 Years’ Experience Gained

Autor Aapro, Matti, Krendyukov, Andriy, Schiestl, Martin, Gascón, Pere
Vydáno v BioDrugs (2018)

Correction to: Epoetin Biosimilars in the Treatment of Chemotherapy-Induced Anemia: 10 Years’ Experience Gained

Autor Aapro, Matti, Krendyukov, Andriy, Schiestl, Martin, Gascón, Pere
Vydáno v BioDrugs (2018)

Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era

Autor Lyman, Gary H., Kuderer, Nicole M., Aapro, Matti
Vydáno v Front Oncol (2021)

Timing flexibility of oral NEPA, netupitant-palonosetron combination, administration for the prevention of chemotherapy-induced nausea and vomiting (CINV)

Autor Baron-Hay, Sally, Aapro, Matti, Bernareggi, Alberto, Schwartzberg, Lee
Vydáno v Support Care Cancer (2019)